𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ex-vivo expansion and maturation of CD34-positive hematopoietic progenitors optimization of culture conditions

✍ Scribed by N Mellado-Damas; J.M Rodrı́guez; M Carmona; J González; J Prieto

Book ID
114119676
Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
94 KB
Volume
23
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum-free ex vivo expansion of CD34+ he
Serum-free ex vivo expansion of CD34+ hematopoietic progenitor cells
✍ Dieter Möbest; Roland Mertelsmann; Reinhard Henschler 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 2 views

In an effort to obtain defined culture conditions for ex vivo expansion of hematopoietic stem and progenitor cells which avoid the supplementation of serum, we cultured human CD34 + hematopoietic progenitor cells in a chemically defined, serum-free medium in the presence of hematopoietic growth fact

Initial CD34+ cell-enrichment of cord bl
Initial CD34+ cell-enrichment of cord blood determines hematopoietic stem/progenitor cell yield upon Ex vivo expansion
✍ Pedro Z. Andrade; Cláudia Lobato da Silva; Francisco dos Santos; Graça Almeida-P 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 334 KB 👁 1 views

## Abstract Since umbilical cord blood (UCB), contains a limited hematopoietic stem/progenitor cells (HSC) number, successful expansion protocols are needed to overcome the hurdles associated with inadequate numbers of HSC collected for transplantation. UCB cultures were performed using a human str

Ex vivo expansion of apheresis-derived p
Ex vivo expansion of apheresis-derived peripheral blood hematopoietic progenitors
✍ Zeev Estrov; Yang O. Huh; Cheryl F. Ginsberg; David Harris; Quin Van; Nadeem Q. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB

## Abstract Because the administration of hematopoietic growth factors and the use of stem cell support often fails to alleviate the neutropenic phase induced by cytotoxic drugs, several investigators have attempted to expand ex vivo hematopoietic progenitors for clinical use. These attempts have c